Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
JANSSEN PHARMACEUTICALS, INC. v. BECERRA et al
Case Number:
3:23-cv-03818
Court:
Nature of Suit:
Judge:
Firms
- Akin Gump
- Buttaci Leardi
- Carella Byrne
- Chiesa Shahinian
- Covington & Burling
- Flitter Milz
- Green Savits
- Lieff Cabraser
- Miller Shah LLP
- Robinson Miller
- Weissman & Mintz
Companies
- AARP Inc.
- American College of Physicians
- American Public Health Association
- American Society of Hematology
- Fresenius Kabi AG
- Public Citizen Inc.
Government Agencies
Sectors & Industries:
-
July 18, 2023
J&J Unit Launches 6th Challenge To Drug Price Negotiations
Johnson & Johnson unit Janssen Pharmaceuticals has launched a suit to challenge a system allowing Medicare to negotiate prescription drug prices under a federal inflation deterrent, marking at least the sixth lawsuit to fight the provision.
- ← Previous
- 1
- 2
- Next →